22.75
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARQT Giù?
Forum
Previsione
Arcutis Biotherapeutics Inc Azioni (ARQT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
30.52%
129.50
|
99.22 | 81.50 | 65.85 | 71.36 |
| Cost Of Revenue |
34.58%
11.69
|
8.685 | 7.492 | 8.83 | 6.905 |
| Gross Profit |
30.13%
117.81
|
90.53 | 74.01 | 57.02 | 64.45 |
|
|
21.24%
99.43
|
82.01 | 88.62 | 81.55 | 72.09 |
| Benefits Costs and Expenses |
22.52%
111.12
|
90.69 | 96.11 | 90.38 | 78.99 |
| Costs And Expenses |
22.52%
111.12
|
90.69 | 96.11 | 90.38 | 78.99 |
| Operating Income/Loss |
115.66%
18.39
|
8.526 | -14.61 | -24.53 | -7.632 |
| Income/Loss From Continuing Operations Before Tax |
115.66%
18.39
|
8.526 | -15.89 | -25.06 | -7.632 |
| Income Tax Expense/Benefit |
487.50%
0.47
|
0.08 | 0.342 | 0.279 | 0.323 |
| Income/Loss From Continuing Operations After Tax |
134.75%
17.39
|
7.41 | -15.89 | -25.06 | -10.79 |
|
|
134.75%
17.39
|
7.41 | -15.89 | -25.06 | -10.79 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.73%
0.343
|
127.62 | 127.00 | 126.04 | 1.3299 |
| Diluted Average Shares |
99.74%
0.343
|
132.88 | 127.00 | 126.04 | 1.3299 |
| Basic Earnings Per Share |
116.67%
0.13
|
0.06 | -0.13 | -0.20 | -0.08 |
| Diluted Earnings Per Share |
116.67%
0.13
|
0.06 | -0.13 | -0.20 | -0.08 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):